Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw.

Frontiers in bioscience (Elite edition) - 1 Jan 2011

Marini Francesca, Tonelli Paolo, Cavalli Loredana, Cavalli Tiziana, Masi Laura, Falchetti Alberto, Brandi Maria Luisa

Abstract excerpt

An undesirable effect associated with bisphosphonates is osteonecrosis of the jaw (ONJ). Case reports discussed ONJ development in patients with multiple myeloma or metastatic cancers receiving bisphosphonates as palliation for malignant bone disease. No causative relationship has been unequivocally demonstrated between ONJ and bisphosphonate therapy. To determine if a higher sensitivity to bisphosphonates could...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Density Conservation Agents
Share to Diphosphonates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imidazoles

Share to Multiple Myeloma

Share to Osteonecrosis

Share to Pharmacogenetics

Share to White People

Source

Identifiers

PMID: 21196316
DOI: 10.2741/e251

Genes

FDPS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw.PMID 21196316Read ↗

Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the JawSemantic proximity Read ↗

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.Semantic proximity Read ↗

Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3.Semantic proximity Read ↗

Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.Semantic proximity Read ↗

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.Semantic proximity Read ↗

Association between CYP2C8 (rs1934951) polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: a meta-analysis.Semantic proximity Read ↗

An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw.Semantic proximity Read ↗

New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw.Semantic proximity Read ↗

Genome-wide Association Study Identified Chromosome 8 Locus Associated with Medication-Related Osteonecrosis of the Jaw.Semantic proximity Read ↗

Biphosphonates-associated osteonecrosis of the jaw: the role of gene-environment interaction.Semantic proximity Read ↗

A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancerSemantic proximity Read ↗

Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.